A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
Jing Li,1,* Haitao Chen,1,2,* Jiaxuan Chen,1,* Bin Zhou,1 Jinlin Hou,1 De-Ke Jiang1 1State Key Laboratory of Organ Failure Research, Guangdong Key Laboratory of Viral Hepatitis Research, Guangdong Institute of Liver Diseases, Department of Infectious Diseases and Hepatology U...
Enregistré dans:
Auteurs principaux: | Li J, Chen H, Chen J, Zhou B, Hou J, Jiang DK |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2ef7983201c24d5987b8832f897f9b8d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
par: Chen-Hsuan Wu, et autres
Publié: (2017) -
Bench Research Informed by GWAS Results
par: Nikolay V. Kondratyev, et autres
Publié: (2021) -
Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy
par: Yu-Li Zeng, et autres
Publié: (2021) -
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
par: Sarah Kadelka, et autres
Publié: (2021) -
Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
par: Nathalie I. V. Nilsson, et autres
Publié: (2021)